Companies

Carlyle Group to acquire majority stake in SeQuent Scientific

Rajesh Kurup Mumbai | Updated on May 08, 2020 Published on May 08, 2020

The Carlyle Group, a global investment firm, has entered into an agreement to acquire a majority stake of up to 74 per cent in Mumbai-based pure-play animal healthcare company, SeQuent Scientific.

While the financial terms of the deal were not disclosed, sources pegged the deal at ₹1,500-1,800 crore. This would be Carlyle’s first acquisition of a controlling stake in an Indian listed company.

Nasdaq-listed The Carlyle Group will acquire a majority stake (up to 50 per cent) in SeQuent through private share purchase agreements at ₹86 per share. The deal would be conducted by CA Harbor Investments, an entity of CAP V Mauritius Ltd (a fund run by Carlyle Group).

The proposed transaction will trigger a mandatory open offer, with CA Harbor Investments planning to acquire up to 26 per cent shares of SeQuent.

The transaction is expected to close in the third quarter of calendar year 2020, following which CA Harbor Investments will become the new promoter of SeQuent.

“We are confident that Carlyle’s global network and resources will be a catalyst for SeQuent’s next stage of growth and innovation,” Arun Kumar, promoter, SeQuent, said.

SeQuent provides animal health Active Pharmaceutical Ingredients, formulations and analytical services in over 100 countries, has more than 1,700 employees. It has manufacturing operations in India, Spain, Turkey, Germany and Brazil.

“We see strong growth potential in the global animal health industry, including the livestock segment where SeQuent is operating, thanks to increasing demand for animal protein, rising awareness of food safety, and growing disposable income,” Neeraj Bharadwaj, Managing Director of the Carlyle Asia Partners team, said.

JP Morgan was the financial advisor, while Nishith Desai Associates was the legal advisor to SeQuent and its promoters. Nomura was the financial advisor while AZB & Partners and White & Case were legal counsels to CA Harbor Investments and Carlyle.

Nomura will be acting as the manager to the public tender offer.

Carlyle has invested more than $2.5 billion in India as of March 31, 2020, with investments in SBI Life, SBI Card, HDFC, India Infoline, Delhivery and PNB Housing Finance. Its investments in the Indian healthcare sector include Medanta Medicity Hospital and Metropolis Healthcare.

Published on May 08, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.